97 related articles for article (PubMed ID: 10554568)
1. [Renaissance of metformin].
Sieradzki J
Przegl Lek; 1999; 56(5):331-4. PubMed ID: 10554568
[TBL] [Abstract][Full Text] [Related]
2. [Serum level of retinol-binding protein 4 in obese patients with insulin resistance and in patients with type 2 diabetes treated with metformin].
Tajtáková M; Semanová Z; Ivancová G; Petrovicová J; Donicová V; Zemberová E
Vnitr Lek; 2007 Sep; 53(9):960-3. PubMed ID: 18019665
[TBL] [Abstract][Full Text] [Related]
3. Metformin: diamonds are forever.
Papanas N; Maltezos E; Mikhailidis DP
Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
[TBL] [Abstract][Full Text] [Related]
4. Current indications for metformin therapy.
Tankova T
Rom J Intern Med; 2003; 41(3):215-25. PubMed ID: 15526505
[TBL] [Abstract][Full Text] [Related]
5. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
Ponssen HH; Elte JW; Lehert P; Schouten JP; Bets D
Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
[TBL] [Abstract][Full Text] [Related]
6. [Lipid anomalies in NIDDM and insulin resistance. Role of metformin].
Isnard F; André P
Journ Annu Diabetol Hotel Dieu; 1992; ():315-30. PubMed ID: 1495250
[No Abstract] [Full Text] [Related]
7. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
8. Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus.
Teranishi T; Ohara T; Maeda K; Zenibayashi M; Kouyama K; Hirota Y; Kawamitsu H; Fujii M; Sugimura K; Kasuga M
Metabolism; 2007 Oct; 56(10):1418-24. PubMed ID: 17884455
[TBL] [Abstract][Full Text] [Related]
9. Effect of metformin therapy on plasma adiponectin and leptin levels in obese and insulin resistant postmenopausal females with type 2 diabetes.
Adamia N; Virsaladze D; Charkviani N; Skhirtladze M; Khutsishvili M
Georgian Med News; 2007 Apr; (145):52-5. PubMed ID: 17525501
[TBL] [Abstract][Full Text] [Related]
10. Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents.
Goodarzi MO; Bryer-Ash M
Diabetes Obes Metab; 2005 Nov; 7(6):654-65. PubMed ID: 16219009
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy of metformin therapy in nonobese individuals with type 2 diabetes.
Ong CR; Molyneaux LM; Constantino MI; Twigg SM; Yue DK
Diabetes Care; 2006 Nov; 29(11):2361-4. PubMed ID: 17065668
[TBL] [Abstract][Full Text] [Related]
12. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
[TBL] [Abstract][Full Text] [Related]
13. Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.
Sheffield CA; Kane MP; Busch RS
Pharmacotherapy; 2007 Oct; 27(10):1449-55. PubMed ID: 17896900
[TBL] [Abstract][Full Text] [Related]
14. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
Stefanović V; Antić S
Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435
[TBL] [Abstract][Full Text] [Related]
15. Metformin: old wine in new bottle--evolving technology and therapy in diabetes.
Joshi SR
J Assoc Physicians India; 2005 Nov; 53():963-72. PubMed ID: 16515237
[TBL] [Abstract][Full Text] [Related]
16. [Effects of glimepiride and metformin on free fatty acid in patients with Type 2 diabetes mellitus].
Tang JZ; Mao JP; Yang ZF; Zhou ZG; Tang WL; Feng Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):631-4. PubMed ID: 16114544
[TBL] [Abstract][Full Text] [Related]
17. Combination of drugs in the management of diabetes mellitus.
Das S
J Indian Med Assoc; 2002 Jul; 100(7):434, 436, 445-7. PubMed ID: 12674168
[TBL] [Abstract][Full Text] [Related]
18. Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus.
Brouwers MC; de Graaf J; van Greevenbroek MM; Schaper N; Stehouwer CD; Stalenhoef AF
Curr Opin Lipidol; 2010 Dec; 21(6):530-8. PubMed ID: 20739883
[TBL] [Abstract][Full Text] [Related]
19. Promising new approaches.
Reasner CA
Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
[TBL] [Abstract][Full Text] [Related]
20. [Aspects of antihyperglycemic oral bitherapy in 76 cases of non insulindependent diabetes in Dakar].
Sidibé EH; Badiane MK; Gueye A
Sante; 2002; 12(3):319-22. PubMed ID: 12473527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
